InterCure Reports H1 2025 Results: NIS 130M Revenue
Ticker: INCR · Form: 6-K · Filed: Oct 8, 2025 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Oct 8, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, revenue, cash-flow
TL;DR
InterCure hit NIS 130M revenue in H1 2025, showing positive cash flow.
AI Summary
InterCure Ltd. reported its first half 2025 results on October 8, 2025, with revenues reaching NIS 130 million and positive operating cash flow. The company filed a Form 6-K, including a press release and condensed consolidated unaudited interim financial statements as of June 30, 2025.
Why It Matters
This filing provides investors with InterCure's recent financial performance, indicating revenue growth and positive cash flow, which are key metrics for assessing the company's operational health.
Risk Assessment
Risk Level: medium — The filing contains financial results, which are standard for public companies, but the specific performance and market conditions can introduce medium-level risk.
Key Numbers
- NIS 130 Million — Revenue (First half 2025 revenue reported)
Key Players & Entities
- Intercure Ltd. (company) — Registrant
- NIS 130 Million (dollar_amount) — First half 2025 revenue
- October 8, 2025 (date) — Date of press release and filing
- June 30, 2025 (date) — Date of financial statements
FAQ
What was InterCure Ltd.'s revenue for the first half of 2025?
InterCure Ltd. reported NIS 130 million in revenue for the first half of 2025.
What type of financial statements were included in the 6-K filing?
The filing included Condensed Consolidated Unaudited Interim Financial Statements as of June 30, 2025.
On what date was the press release regarding the first half 2025 results issued?
The press release was issued on October 8, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 85 Medinat ha-Yehudim Street, Herzliya, 4676670, Israel.
Does InterCure Ltd. file annual reports under Form 20-F or 40-F?
InterCure Ltd. files annual reports under Form 20-F.
Filing Stats: 397 words · 2 min read · ~1 pages · Grade level 12.4 · Accepted 2025-10-08 08:50:10
Filing Documents
- form6-k.htm (6-K) — 18KB
- ex99-1.htm (EX-99.1) — 102KB
- ex99-2.htm (EX-99.2) — 290KB
- ex99-3.htm (EX-99.3) — 97KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-25-017373.txt ( ) — 516KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTERCURE LTD. Date: October 8, 2025 /s/ Amos Cohen Amos Cohen Chief Financial Officer